08.01.2014 Views

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Version 4.0<br />

<strong>VA</strong>/<strong>DoD</strong> <strong>Clinical</strong> <strong>Practice</strong> <strong>Guideline</strong><br />

for the Management of Diabetes Mellitus<br />

J. Initiate/Adjust Therapy<br />

OBJECTIVE<br />

Achieve glycemic target goals by the most cost-effective and least invasive means.<br />

BACKGROUND<br />

Long-term outcomes of treatment of <strong>DM</strong> (i.e., microvascular complications) are related to the degree of glycemic<br />

control but not to the means used to achieve it (i.e., diet/exercise versus oral hypoglycemic agent versus insulin, or<br />

any known combination therapy). Based on this principle, therapy should be tailored to individual preferences,<br />

needs, and pragmatic considerations, such as cost and ease of compliance.<br />

RECOMMENDATIONS<br />

1. Individual treatment goals must be established with the patient based on the extent of the disease, comorbid<br />

conditions, and patient preferences.<br />

2. Institution of dietary modification and exercise alone is usually the appropriate initial management in<br />

patients with new onset type 2 diabetes, depending upon severity of symptoms, psychosocial evaluation,<br />

patient motivation, and overall health status. Encourage diet and exercise and lifestyle modifications.<br />

3. Use various approaches (e.g., individual or group, counseling, coaching, motivational interviewing) to<br />

promote healthful behaviors, such as healthful diet, adequate physical activity, and smoking cessation.<br />

4. If treatment goals are not achieved with diet and exercise alone, drug therapy should be initiated while<br />

encouraging lifestyle modifications.<br />

The concept of sequential treatment is commonly employed in clinical management of chronic diseases. The<br />

sequential steps for glycemic control therapy are summarized in Figure G1.<br />

DISCUSSION<br />

Non-Pharmacologic Therapy<br />

Each patient with newly diagnosed type 2 <strong>DM</strong> without markedly elevated HbA 1 c or symptomatic hyperglycemia<br />

should be offered trial of non-pharamcological therapy with diet and lifestyle modification prior to the use of<br />

medications. Lifestyle changes include diet (see Module M, Self-management and Education), exercise for at least<br />

30 minutes per day on most days of the week (as appropriate, after a detailed medical examination), weight loss if<br />

indicated, and smoking cessation. Limit alcohol to no more than 2 drinks per day for men and 1 drink per day for<br />

women (1 drink=12 ounces of beer, 5 ounces of wine, or 1.5 ounces of distilled spirits). Dietary modicficaion and<br />

exercise should be given at least a 3 month trial before drug therapy is started, unless fasting glucose >250 mg/dL or<br />

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!